nach oben

Breast Cancer Research and Treatment

Erschienen in:

01.07.2008 | Review

Prognosis of the upper limb following surgery and radiation for breast cancer

verfasst von: Teresa S. Lee, Sharon L. Kilbreath, Kathryn M. Refshauge, Robert D. Herbert, Jane M. Beith

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

The aim of this systematic review was to identify the prevalence and severity of upper limb problems following surgery and radiation for early breast cancer. Additionally, the independent prognostic contribution of radiation, type of breast surgery, type of axillary surgery, age and body mass index (BMI) was evaluated. Searches of electronic databases were conducted to identify articles that reported upper limb and quality of life outcomes after breast cancer surgery and external radiation. Eligible studies for prognosis were longitudinal in design, with ≥95% of patients treated by surgery and radiation that excluded the axilla. Cross-sectional studies were also included for identification of prognostic factors. Where possible, the contribution of independent prognostic factors was analyzed. The review identified 32 relevant studies. Shoulder restriction was reported in between <1% and 67% of participants, lymphedema was reported in between 0 and 34% of participants, shoulder/arm pain was reported in between 9 and 68% of participants and arm weakness was reported in between 9 and 28% of participants. Quality of life was high across studies. Irradiated patients had slightly increased odds of lymphedema (OR = 1.46, 95% CI 1.16–1.84) and shoulder restriction (OR = 1.67, 95% CI 0.98–2.86) compared with non-irradiated patients. For patients undergoing surgery and radiation for breast cancer, the prognosis is good in terms of the upper limb and quality of life. Radiation that excludes the axilla does not appear to be a strong prognostic indicator of adverse upper limb outcomes.

Nur mit Berechtigung zugänglich

Centers for disease control and prevention (2004) Cancer survivorship – United States, 1971–2001. Morbidity and Mortality Weekly Report 53:526–529

Collins LG, Nash R, Round T et al (2004) Perceptions of upper-body problems during recovery from breast cancer treatment. Support Care Cancer 12:106–113PubMedCrossRef

McCredie MRE, Dite GS, Porter L et al (2001) Prevalence of self-reported arm morbidity following treatment for breast cancer in the Australian Breast Cancer Family Study. Breast 10:515–522PubMedCrossRef

Warner NJ, Rangan AM, Langlands AO et al (1998) Effect of concurrent chemotherapy and radiotherapy on breast cosmesis: a study of patients’ perceptions. Breast 7:131–136CrossRef

Sugden EM, Rezvani M, Harrison JM et al (1998) Shoulder movement after the treatment of early stage breast cancer. Clin Oncol (R Coll Radiol) 10:173–181

The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer (1998) Mastectomy or lumpectomy? The choice of operation for clinical Stages I and II breast cancer. CMAJ 158(Suppl 3):S15–S21

Kissin MW, Querci della Rovere G, Easton D et al (1986) Risk of lymphoedema following the treatment of breast cancer. Br J Surg 73:580–584PubMedCrossRef

Kwan W, Jackson J, Weir LM et al (2002) Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol 20:4242–4248PubMedCrossRef

Nagel PH, Bruggink ED, Wobbes T et al (2003) Arm morbidity after complete axillary lymph node dissection for breast cancer. Acta Chir Belg 103:212–216PubMed

10.

Chetty U, Jack W, Prescott RJ et al (2000) Management of the axilla in operable breast cancer treated by breast conservation: a randomized clinical trial. Br J Surg 87:163–169PubMedCrossRef

11.

Delouche G, Bachelot F, Premont M et al (1987) Conservation treatment of early breast cancer: long term results and complications. Int J Radiat Oncol Biol Phys 13:29–34PubMed

12.

Johansson K, Ingvar C, Albertsson M et al (2001) Arm lymphoedema, shoulder mobility and muscle strength after breast cancer treatment – a prospective 2-year study. Adv Physioth 3:55–66CrossRef

13.

Schrenk P, Rieger R, Shamiyeh A et al (2000) Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88:608–614PubMedCrossRef

14.

Giuliano AE, Haigh PI, Brennan MB et al (2000) Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 18:2553–2559PubMed

15.

Mansel RE, Fallowfield L, Kissin M et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98:599–609PubMedCrossRef

16.

Ward S, Heidrich S, Wolberg W (1989) Factors women take into account when deciding upon type of surgery for breast cancer. Cancer Nurs 12:344–351PubMedCrossRef

17.

Pengel LHM, Herbert RD, Maher CG et al (2003) Acute low back pain: systematic review of its prognosis. BMJ 327:323PubMedCrossRef

18.

de Noronha M, Refshauge KM, Herbert RD et al (2006) Do voluntary strength, proprioception, range of motion, or postural sway predict occurrence of lateral ankle sprain? BJSM 40:824–828CrossRefPubMed

19.

Muaidi Q, Nicholson L, Refshauge K et al (in press) Prognosis of conservatively managed anterior cruciate ligament injury: a systematic review. Sports Medicine

20.

Schulz KF, Chalmers I, Hayes RJ et al (1995) Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273:408–412PubMedCrossRef

21.

Emerson JD, Burdick E, Hoaglin DC et al (1990) An empirical study of the possible relation of treatment differences to quality scores in controlled randomized clinical trials. Control Clin Trials 11:339–352PubMedCrossRef

22.

Delgado-Rodriguez M, Sillero Arenas M (1995) Inclusion of research quality in meta-analyses. Gac Sanit 9:265–272PubMed

23.

Ernst MF, Voogd AC, Balder W et al (2002) Early and late morbidity associated with axillary levels I-III dissection in breast cancer. J Surg Oncol 79:151–155PubMedCrossRef

24.

Tengrup I, Tennvall-Nittby L, Christiansson I et al (2000) Arm morbidity after breast-conserving therapy for breast cancer. Acta Oncol 39:393–397PubMedCrossRef

25.

Voogd AC, Ververs JM, Vingerhoets AJ et al (2003) Lymphoedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancer. Br J Surg 90:76–81PubMedCrossRef

26.

Parvanova V, Pandova V (1999) Radiotherapy without boost to the tumor bed after conservative surgery in the treatment of early breast cancer. J BUON 4:179–184

27.

Barranger E, Dubernard G, Fleurence J et al (2005) Subjective morbidity and quality of life after sentinel node biopsy and axillary lymph node dissection for breast cancer. J Surg Oncol 92:17–22PubMedCrossRef

28.

Knobf MT, Sun Y (2005) A longitudinal study of symptoms and self-care activities in women treated with primary radiotherapy for breast cancer. Cancer Nurs 28:210–218PubMedCrossRef

29.

Lee TS, Kilbreath SL, Refshauge KM et al (2007) Pectoral stretching program for women undergoing radiotherapy for breast cancer. Breast Cancer Res Treat 102:313–321PubMedCrossRef

30.

Peintinger F, Reitsamer R, Stranzl H et al (2003) Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer 89:648–652PubMedCrossRef

31.

Fehlauer F, Tribius S, Holler U et al (2003) Long-term radiation sequelae after breast-conserving therapy in women with early-stage breast cancer: an observational study using the LENT-SOMA scoring system. Int J Radiat Oncol Biol Phys 55:651–658PubMed

32.

Ishiyama H, Niino K, Hosoya T et al (2006) Results of a questionnaire survey for symptom of late complications caused by radiotherapy in breast conserving therapy. Breast Cancer 13:197–201PubMedCrossRef

33.

Kiel KD, Rademacker AW (1996) Early-stage breast cancer: arm edema after wide excision and breast irradiation. Radiology 198:279–283PubMed

34.

Sarin R, Dinshaw KA, Shrivastava SK et al (1993) Therapeutic factors influencing the cosmetic outcome and late complications in the conservative management of early breast cancer. Int J Radiat Oncol Biol Phys 27:285–292PubMed

35.

Borger JH, Keijser AH (1987) Conservative breast cancer treatment: analysis of cosmetic results and the role of concomitant adjuvant chemotherapy. Int J Radiat Oncol Biol Phys 13:1173–1177PubMed

36.

Yap KP, McCready DR, Narod S et al (2003) Factors influencing arm and axillary symptoms after treatment for node negative breast carcinoma. Cancer 97:1369–1375PubMedCrossRef

37.

Meric F, Buchholz TA, Mirza NQ et al (2002) Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol 9:543–549PubMedCrossRef

38.

Tasmuth T, von Smitten K, Hietanen P et al (1995) Pain and other symptoms after different treatment modalities of breast cancer. Ann Oncol 6:453–459PubMed

39.

Amichetti M, Busana L, Caffo O (1995) Long-term cosmetic outcome and toxicity in patients treated with quadrantectomy and radiation therapy for early-stage breast cancer. Oncology 52:177–181PubMedCrossRef

40.

Toledano A, Garaud P, Serin D et al (2006) Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: Long-term results of the ARCOSEIN multicenter randomized study. Int J Radiat Oncol Biol Phys 65:324–332PubMed

41.

Herd-Smith A, Russo A, Muraca MG et al (2001) Prognostic factors for lymphedema after primary treatment of breast carcinoma. Cancer 92:1783–1787PubMedCrossRef

42.

Schulze T, Mucke J, Markwardt J et al (2006) Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. J Surg Oncol 93:109–119PubMedCrossRef

43.

Clark B, Sitzia J, Harlow W (2005) Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study. QJM 98:343–348PubMedCrossRef

44.

Amichetti M, Caffo O (2003) Pain after quadrantectomy and radiotherapy for early-stage breast cancer: incidence, characteristics and influence on quality of life. Results from a retrospective study. Oncology 65:23–28PubMedCrossRef

45.

Whelan TJ, Levine M, Julian J et al (2000) The effects of radiation therapy on quality of life of women with breast carcinoma: results of a randomized trial. Ontario Clinical Oncology Group. Cancer 88:2260–2266PubMedCrossRef

46.

Rayan G, Dawson LA, Bezjak A et al (2003) Prospective comparison of breast pain in patients participating in a randomized trial of breast-conserving surgery and tamoxifen with or without radiotherapy. Int J Radiat Oncol Biol Phys 55:154–161PubMedCrossRef

47.

Back M, Ahern V, Delaney G et al (2005) Absence of adverse early quality of life outcomes of radiation therapy in breast conservation therapy for early breast cancer. Australas Radiol 49:39–43PubMedCrossRef

48.

Schou I, Ekeberg O, Sandvik L et al (2005) Multiple predictors of health-related quality of life in early stage breast cancer. Data from a year follow-up study compared with the general population. Qual Life Res 14:1813–1823PubMedCrossRef

49.

Liljegren G, Holmberg L (1997) Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage I. Results from a randomised trial. Uppsala-Orebro Breast Cancer Study Group. Eur J Cancer 33:193–199PubMedCrossRef

50.

Box RC, Reul-Hirche HM, Bullock-Saxton JE et al (2002) Physiotherapy after breast cancer surgery: results of a randomised controlled study to minimise lymphoedema. Breast Cancer Res Treat 75:51–64PubMedCrossRef

51.

Engel J, Kerr J, Schlesinger-Raab A et al (2003) Axilla surgery severely affects quality of life: results of a 5-year prospective study in breast cancer patients. Breast Cancer Res Treat 80:47–57CrossRef

52.

Lauridsen MC, Torsleff KR, Husted H et al (2000) Physiotherapy treatment of late symptoms following surgical treatment of breast cancer. Breast 9:45–51PubMedCrossRef

53.

Burak WE, Hollenbeck ST, Zervos EE et al (2002) Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 183:23–27PubMedCrossRef

54.

Schwarz R, Hinz A (2001) Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 37:1345–1351PubMedCrossRef

55.

Cella D, Hahn EA, Dineen K (2002) Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening. Qual Life Res 11:207–221PubMedCrossRef

56.

Maguire P (1999) Late adverse psychological sequelae of breast cancer and its treatment. Eur J Surg Oncol 25:317–320PubMedCrossRef

57.

Hayes S, Cornish B, Newman B (2005) Comparison of methods to diagnose lymphoedema among breast cancer survivors: 6-month follow-up. Breast Cancer Res Treat 89:221–226PubMedCrossRef

Titel: Prognosis of the upper limb following surgery and radiation for breast cancer
verfasst von: Teresa S. Lee
Sharon L. Kilbreath
Kathryn M. Refshauge
Robert D. Herbert
Jane M. Beith
Publikationsdatum: 01.07.2008
Verlag: Springer US
Erschienen in: Breast Cancer Research and Treatment / Ausgabe 1/2008
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-007-9710-9

Springer Medizin

Prognosis of the upper limb following surgery and radiation for breast cancer

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2008

Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer

Survival in breast cancer is familial

The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified

Anti-estrogenic mechanism of unliganded progesterone receptor isoform B in breast cancer cells

Cognitive function in breast cancer patients prior to adjuvant treatment

Intermediate to highly suspicious calcification in breast lesions: a radio-pathologic correlation

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie